Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Catherine Laborde, who presented weather on TF1 in France for nearly 30 years, has died. Laborde passed away on Tuesday, Jan. 28 following a years-long battle with Lewy Body Dementia (LBD), which she ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

EZH1 is a key regulator of circadian rhythms, stabilizing gene transcription and modifying chromatin to maintain genetic ...

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, ...